Aortocoronary endothelial cell-seeded polytetrafluoroethylene graft: 9-year patency.
We report a 71-year old man with coronary artery disease. Complete coronary revascularization was not possible with autologous grafts; therefore, a 4-mm expanded polytetrafluoroethylene graft was implanted that had been seeded preoperatively with autologous vascular endothelial cells. At 9-year follow-up, the patient is asymptomatic and shows a patent graft.
Gabbieri
Davide
D
Department of Cardiovascular Surgery, Charité Hospital, Medical University Berlin, Germany. dgabbieri@yahoo.it
Dohmen
Pascal M
PM
Koch
Christina
C
Lembcke
Alexander
A
Rutsch
Wolfgang
W
Konertz
Wolfgang
W
D000368:Aged; D001011:Aorta; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D003331:Coronary Vessels; D042783:Endothelial Cells / Q000637:transplantation*; D006801:Humans; D008297:Male; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D013997:Time Factors; D014182:Transplantation, Autologous; D014654:Vascular Patency
D011138:Polytetrafluoroethylene